Does the indication for revision associate with the outcomes of revision total knee arthroplasty? A retrospective analysis with a minimum ten-year follow-up

Author:

Lin Yu-Chih1,Chang Chih-Hsiang1,Hu Chih-Chien1,Chang Yuhan1,Lee Sheng-Hsun1,Lin Sheng-Hsuan2

Affiliation:

1. Chang Gung Memorial Hospital (CGMH)

2. National Yang Ming Chiao Tung University

Abstract

Abstract Background The long-term outcome of revision total knee arthroplasty (rTKA) remains variable. We aimed to determine whether the indication for revision affects rTKA outcomes and assess the risk factors for rTKA failure. Methods We reviewed all patients who underwent their first rTKA at our institution between January 2003 and December 2011. Patients were grouped based on the indication for revision. All patients with septic indications underwent staged exchange arthroplasty for periprosthetic joint infection (PJI). Demographic and perioperative variables were compared to analyze the survivorships and the risk factors for treatment failure and implant failure between septic and aseptic indications. Results Two-hundred-and-thirty patients (septic indication, 116 patients; aseptic indication, 114 patients) were included. The minimum follow-up duration was 10.3 years (mean: 12.3 years; range: 10.3–19.1 years). The overall treatment success rate of rTKA was 88.3% (203/230). The septic group had a significantly higher failure rate (18.10% vs. 5.26%, p < 0.05) and required earlier re-operation after index revision (14.6 vs. 23.0 months, p < 0.05) than the aseptic group. The identified risk factor in septic group for treatment failure and implant failure is “higher CRP level (> 100 mg/dl) during the first PJI episode before index revision” and “debridement, antibiotics, and implant retention procedure (DAIR) after index rTKA”, respectively. Severe osteoporosis with a history of periprosthetic fracture is the only independent risk factor for implant failure in aseptic group. Conclusions One-third of patients with septic indication for rTKA underwent re-operation, mostly for PJI. Identified risk factors for different indications could associate with unfavorable survivorships.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3